PPA
Studies have shown that PPA (phenylpropanolamine), a common
ingredient in hundreds of cough-and-cold medicines and
appetite suppressants prior to November 2000, is associated
with an increased risk of stroke. Manufacturers of products
such as Alka-Seltzer Plus, Contac 12-Hour Cold, Dexatrim
Extended Duration, Dexatrim Gelcaps, Dimetapp Elixir,
Neldecon DX, Robitussin CF, just to name a few, have exposed
millions of consumers to an unnecessarily high risk of
experiencing stroke.
Ephedra
Ephedra, an extract of the Chinese Ma Huang herb, is
commonly used in products marketed as appetite suppressants
and fat-burners, including Metabolife, Dexatrim Natural,
Ripped Fuel, Herbal Fen-Phen, and ECA Stack. Ephedra
is also an ingredient in the asthma medication Primatene.
Studies show that ephedra, like PPA, has been linked
to an increased risk of stroke, as well as other serious
adverse events such as seizures, heart attack, psychosis
and death.
If you or a family member has suffered
one of these serious adverse events while using a product
containing PPA or ephedra, we encourage you to contact
LeBlanc & Waddell attorney Paul Wilkins to discuss
your legal rights.
If you would like to speak with someone
concerning use of PPA/Ephedra, you may discuss your
particular situation with an experienced attorney at
the law offices of LeBlanc & Waddell by contacting
us online, by telephone at 800-988-3514, or by fax at
225-768-7999.
|
